(Press-News.org) Bonn, December 20, 2023 - Prof. Mark Coburn and PD Dr. Ana Kowark from the Department of Anesthesiology and Operative Intensive Care Medicine at the University Hospital Bonn (UKB) have conducted the largest randomized study to date on the effect of preoperative, orally administered midazolam in older patients. Placebo-controlled, the physicians revealed that midazolam does not impair patient satisfaction and safety when used in low doses. The results were published today in the renowned journal JAMA Surgery.
Midazolam is a sedative from the benzodiazepine group. It is sometimes used in anesthesia to calm patients before an operation. "Despite its widespread use, the effect of oral administration of midazolam on patient satisfaction in older patients before an operation has not yet been conclusively clarified," says Prof. Mark Coburn, Director of the Department of Anesthesiology and Intensive Care Medicine at the UKB. For this reason, the largest randomized study with placebo control to date on this issue was conducted in nine German hospitals. The more than 600 study participants were between 65 and 80 years old and were about to undergo elective surgery with at least 30 minutes of general anesthesia and planned extubation.
About half of the study participants were given a single low oral dose of midazolam 3.75 mg, the other half received placebos. The evaluation included a questionnaire to be completed one day after the operation and the monitoring of vital signs, possible complications and cognitive recovery within one month of the operation. "We revealed that there was no difference in patient safety between the midazolam group and the placebo group - apart from a higher proportion of hypertensive patients in the placebo group. A single low-dose medication of midazolam in older patients before surgery or with anxiety does not change patient satisfaction or patient safety," says PD Dr. Ana Kowark, senior physician at the Department of Anesthesiology and Operative Intensive Care Medicine at the UKB and first author of the publication.
Original publication:
Ana Kowark, MD; András P Keszei, PhD; Gerhard Schneider, MD; Stefanie Pilge, MD; Frederick Schneider, MD; David P Obert, MD; Marie-Therese Georgii, MD; Markus Heim, MD; Rolf Rossaint, MD; Sebastian Ziemann, MD; Julia van Waesberghe, MD; Michael Czaplik, PhD; Friedrich K Pühringer, MD; Christian Minarski, MD; Verena May, MD; Tobias Malisi, MD; Berthold Drexler, MD; Carmen Maria Ring, MD; Phillip Engler, MD; Roman Tilly, MD; Petra Bischoff, MD; Ulrich Frey, MD; Maria Wittmann, MD; Martin Soehle, MD; Thomas Saller, MD; Peter Kienbaum, MD; Moritz Kretzschmar, PhD; Mark Coburn*, MD; for the I-PROMOTE study group; Preoperative Midazolam and Patient-Centered Outcomes of Older Patients; DOI: 10.1001/jamasurg.2023.6479
Press contact:
Viola Röser
Press Officer at the University Hospital Bonn (UKB)
Communications and Media Office at the University Hospital Bonn
Phone +49 228 287- 10649
E-mail: viola.roeser@ukbonn.de
About Bonn University Hospital: Around 500,000 patients are treated at the UKB every year, it employs around 9,000 staff and has a balance sheet total of 1.6 billion euros. In addition to over 3,300 medical and dental students, a further 585 people are trained in numerous healthcare professions each year. The UKB is ranked first among university hospitals in NRW in the science ranking and in the Focus clinic list and has the third highest case mix index (case severity) in Germany. In 2022 and 2023, the F.A.Z. Institute recognized the UKB as Germany's most desirable employer and training champion among public hospitals in Germany.
END
Physicians at the University Hospital Bonn investigated the effect of preoperative midazolam in older patients for the first time in a large randomized study
Patient satisfaction and safety remain unchanged with low-dose oral administration
2023-12-20
ELSE PRESS RELEASES FROM THIS DATE:
Cells of the future: A key to reprogramming cell identities
2023-12-20
The intricate process of duplicating genetic information, referred to as DNA replication, lies at the heart of the transmission of life from one cell to another and from one organism to the next. This happens by not just simply copying the genetic information; a well-orchestrated sequence of molecular events has to happen at the right time. Scientists around Prof. Maria-Elena Torres-Padilla from Helmholtz Munich have recently uncovered a fascinating aspect of this process known as "replication timing" (RT) and how special this is when life commences. The new results are now published in Nature. ...
One small material, one giant leap for life on Mars: Sussex research takes us a step closer to sustaining human life on the red planet
2023-12-20
A mineral found on the surface of Mars offers potential to create sustainable energy
Uses ‘waste’ product from recent NASA research to create transformative nanomaterials
Findings could play role in shaping sustainable habitation on the red planet – and clean energy production back home
Researchers at the University of Sussex have discovered the transformative potential of Martian nanomaterials, potentially opening the door to sustainable habitation on the red planet.
Using resources and techniques currently applied on the International Space Station and by NASA, Dr Conor Boland, a Lecturer in Materials Physics at the University of Sussex, led a ...
AIBS announces winners of 2023 Faces of Biology Photo Contest
2023-12-20
Three winners have been selected in the 2023 Faces of Biology Photo Contest, sponsored by the American Institute of Biological Sciences (AIBS) and the Society for Integrative and Comparative Biology (SICB).
“Photography is an effective tool to help communicate the process of scientific research,” said Scott Glisson, CEO of AIBS. “This contest provides a visual forum for expression, inspiration, and technical skill that can have a positive impact on how the public views research and science.
The competition showcases, in a personal way, biological research in its many forms and settings. With the images, we ...
Using AI, MIT researchers identify a new class of antibiotic candidates
2023-12-20
CAMBRIDGE, MA – Using a type of artificial intelligence known as deep learning, MIT researchers have discovered a class of compounds that can kill a drug-resistant bacterium that causes more than 10,000 deaths in the United States every year.
In a study appearing today in Nature, the researchers showed that these compounds could kill methicillin-resistant Staphylococcus aureus (MRSA) grown in a lab dish and in two mouse models of MRSA infection. The compounds also show very low toxicity against human cells, making them particularly good drug candidates.
A key innovation of the new study is that the researchers were also able to figure out ...
A trillion scents, one nose
2023-12-20
The mammalian nose is a work of evolutionary art. Its millions of nerve cells, each tailored with just one of thousands of specific odor-chemical receptors encoded in the genome, can collectively distinguish a trillion distinct scents. Those sensations, in turn, inform many behaviors, from assessing food options to discerning friends from foes to sparking memories.
Today, in the journal Nature, a research team led by scientists at Columbia’s Zuckerman Institute describes a previously undetected mechanism in mice—starring the genetic molecule RNA—that could explain how each sensory cell, or neuron, in mammalian noses becomes tailored to detect a specific ...
Innovation in development of dermatologic drugs approved by the FDA
2023-12-20
About The Study: Compared with prior decades, the number of new dermatologic drug approvals by the Food and Drug Administration (FDA) increased between 2012 and 2022. Nearly half of these drugs were considered first in class or first in indication, and several were deemed clinically useful or to have high added therapeutic benefit by health technology assessment organizations in Germany, Canada, or France.
Authors: Ravi Gupta, M.D., M.S.H.P., of the Johns Hopkins University School of Medicine ...
New brain-like transistor mimics human intelligence
2023-12-20
Taking inspiration from the human brain, researchers have developed a new synaptic transistor capable of higher-level thinking.
Designed by researchers at Northwestern University, Boston College and the Massachusetts Institute of Technology (MIT), the device simultaneously processes and stores information just like the human brain. In new experiments, the researchers demonstrated that the transistor goes beyond simple machine-learning tasks to categorize data and is capable of performing associative learning.
Although previous studies have leveraged similar strategies to develop brain-like computing devices, those transistors cannot function outside cryogenic temperatures. The new ...
Home-delivered meals and nursing home placement among people with self-reported dementia
2023-12-20
About The Study: This pilot pragmatic clinical trial included 243 homebound older adults with self- or proxy-reported dementia found a lower although nonsignificant likelihood of nursing home placement among those receiving daily-delivered meals compared with those receiving drop-shipped frozen meals. While this study was not powered to detect meaningful, statistically significant differences in nursing home placement, its feasibility and initial results warrant exploration in an adequately powered trial.
Authors: Kali S. Thomas, Ph.D., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding author.
To access the embargoed ...
Integrating research and clinical care to uncover secrets of brain development
2023-12-20
The human brain continues to be built after we are born for far longer than previously recognized, suggests research by Shawn Sorrells, assistant professor of neuroscience in the Kenneth P. Dietrich School of Arts and Sciences. Sorrells’s research on postnatal brain development, published today inthe journal Nature, shines light on fundamental processes that contribute to the development of important brain functions, such as learning, memory and spatial navigation.
The new research suggests that a subset of inhibitory neurons within the entorhinal cortex, or EC -- an area of the brain essential for forming memories -- continue ...
Meet 'Coscientist,' your AI lab partner
2023-12-20
In less time than it will take you to read this article, an artificial intelligence-driven system was able to autonomously learn about certain Nobel Prize-winning chemical reactions and design a successful laboratory procedure to make them. The AI did all that in just a few minutes — and nailed it on the first try.
"This is the first time that a non-organic intelligence planned, designed and executed this complex reaction that was invented by humans," says Carnegie Mellon University chemist and ...
LAST 30 PRESS RELEASES:
Process for dealing with sexual misconduct by doctors requires major reform
Severe pregnancy sickness raises risk of mental health conditions by over 50%
Early humans may have walked from Türkiye to mainland Europe, new groundbreaking research suggests
New study shows biochar’s electrical properties can influence rice field methane emissions
Guangdong faces largest chikungunya outbreak on record
Tirzepatide improves blood sugar control in children aged 10-17 years with type 2 diabetes inadequately controlled on existing therapies (SURPASS-PEDS trial)
An old drug, in a low dose, shown to be safe and effective in preventing progression of type 1 diabetes in children and young people (MELD-ATG trial)
Study reports potential effects of verapamil in slowing progression of type 1 diabetes
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at 2-year follow-up
New estimates predict over 4 million missing people who would be alive in 2025 if not for inadequate type 1 diabetes care
So what should we call this – a grue jay?
Chicago Quantum Exchange-led coalition advances to final round in NSF Engine competition
Study identifies candidates for therapeutic targets in pediatric germ cell tumors
Media alert: The global burden of CVD
Study illuminates contributing factors to blood vessel leakage
What nations around the world can learn from Ukraine
Mixing tree species does not always make forests more drought-resilient
Public confidence in U.S. health agencies slides, fueled by declines among Democrats
“Quantum squeezing” a nanoscale particle for the first time
El Niño spurs extreme daily rain events despite drier monsoons in India
Two studies explore the genomic diversity of deadly mosquito vectors
Zebra finches categorize their vocal calls by meaning
Analysis challenges conventional wisdom about partisan support for US science funding
New model can accurately predict a forest’s future
‘Like talking on the telephone’: Quantum computing engineers get atoms chatting long distance
Genomic evolution of major malaria-transmitting mosquito species uncovered
Overcoming the barriers of hydrogen storage with a low-temperature hydrogen battery
Tuberculosis vulnerability of people with HIV: a viral protein implicated
Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living
Decoding the selfish gene, from evolutionary cheaters to disease control
[Press-News.org] Physicians at the University Hospital Bonn investigated the effect of preoperative midazolam in older patients for the first time in a large randomized studyPatient satisfaction and safety remain unchanged with low-dose oral administration